Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2023-08-16 00:00:00 ET · period of report 2023-08-14 · accession 0001714899-23-000125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-08-16 | 2023-08-14 | DNLI | Ho Carole | Chief Medical Off | S - Sale | $23.79 | -2,768 | 182.8K | -1% | -$65.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-14 | S | D | 2,768 | $23.79 | 182,809 | I See footnote | — | — | (F2) The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. |